FIBROBIOLOGICS INC. - COMMON STOCK

1.8100

12-February-25 12:14:15

15 minutes delayed

Stocks

+0.0900

+5.23%

Today's range

1.6600 - 1.8800

ISIN

N/A

Source

NASDAQ

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

06 Jun 2024 08:31:00 By Nasdaq GlobeNewswire
FibroBiologics Announces 2024 Annual Meeting of Stockholders

15 May 2024 15:30:00 By Nasdaq GlobeNewswire
FibroBiologics Files 2024 First Quarter Report

14 May 2024 16:24:58 By Nasdaq GlobeNewswire
FibroBiologics to Present at the BIO International Convention 2024

07 May 2024 08:31:00 By Nasdaq GlobeNewswire
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

25 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

11 Apr 2024 08:31:00 By Nasdaq GlobeNewswire
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

04 Apr 2024 08:31:00 By Nasdaq GlobeNewswire
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

28 Mar 2024 08:31:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.